Singapore
Mirxes refiled its draft IPO prospectus with a target to raise at least $100 million.
PhonePe, Google Pay to benefit as India may delay market share cap on UPI payments
Sony, others eye Japanese online comic store Infocom in $1.3b deal: report
Chinese telehealth firm TaiDoc Health snaps over $127m from investors
Hong Kong’s i2Cool bags nearly $13m in Series A funding round
US-based Zenas BioPharma closes upsized Series C round at $200m
More Stories
CVC-led group to buy 65% stake in Lippo-backed hospital chain Siloam for around $1.6b
Malaysia-based PE firm Navis likely to lead funding in CarDekho’s SE Asian entity
Japan’s Reazon Capital eyes 8 SE Asia investments this year
Sale process of Malaysia’s Island Hospital by PE firm Affinity draws investors
IPO-bound SG biotech startup Mirxes losses widen in 2023 despite revenue jump
Greater China
This marks a second consecutive quarter of investment income gain.
Indonesia
Blibli’s take rate increased to 6.3% in Q1 2024, compared with 4.9% in Q1 2023.
World
KKR’s PE portfolio appreciated 5%, opportunistic real estate funds gained 1%, and leveraged credit funds added 3%.
The firm posted its weakest quarterly profit growth since 2022, while revenue growth slowed to a nearly 4-year low.
Bukalapak attributes the performance to top-line growth, thriving take rate and excellent cost control
The firm has signed a deal to sell its logistics and delivery businesses.
Alphabet and Microsoft ignited a rally in tech stocks on Friday.
The NPL ratio stood at 0.6%, way below the industry average of 2.3%.
Marketing expenses, which rose 76% YoY, were among the company’s biggest costs in 2022.